Avalyn Pharma Inc. (NASDAQ:AVLN)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$105.7M
- Net margin
- —
Little or no net debt.
- Total debt
- $2.1M
- Cash
- $145.4M
- Debt / equity
- 0.01
Comfortably covers what is due within a year.
- Current assets
- $333.7M
- Current liabilities
- $13.0M
- Current ratio
- 25.76
Consumes cash and must keep raising it.
- Operating cash flow
- -$102.9M
- Free cash flow
- -$103.6M
Some dilution over the past year.
- Shares outstanding
- 0.0M
- Share growth (1y)
- —
- Cash runway
- 17 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
AVLN Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue Growth (YoY) | — | — | — | — | — |
| Cost of Revenue | $0.00 | $110.00 K | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | -$110.00 K | $0.00 | $0.00 | $0.00 |
| SG&A Expense | $7.60 M | $6.45 M | $5.02 M | $3.90 M | $3.40 M |
| R&D Expense | $25.49 M | $24.73 M | $22.89 M | $17.88 M | $15.32 M |
| Operating Expenses | $33.09 M | $31.18 M | $27.91 M | $21.78 M | $18.72 M |
| Operating Income | -$33.09 M | -$31.29 M | -$27.91 M | -$21.78 M | -$18.72 M |
| Pretax Income | -$29.66 M | -$28.93 M | -$26.87 M | -$20.19 M | -$17.50 M |
| Tax Provision | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$29.66 M | -$28.93 M | -$26.87 M | -$20.19 M | -$17.50 M |
| EPS (Basic) | $0.00 | -$0.65 | -$0.64 | -$0.48 | -$0.42 |
| EPS (Diluted) | $0.00 | -$0.65 | -$0.64 | -$0.48 | -$0.42 |
| Shares Outstanding | 0.00 | 44.33 M | 41.81 M | 41.81 M | 41.81 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.